MedTech Dive May 7, 2024
Susan Kelly

A proposed separation of Masimo’s consumer business, which is currently under consideration, would likely include the Stork monitoring system.

Dive Brief:

  • Masimo said it received Food and Drug Administration approval for its Stork baby monitor for purchase without a prescription. The over-the-counter system offers the same pulse oximetry technology as Masimo devices used in hospitals, the company said Monday.
  • The at-home version continuously monitors oxygen saturation, pulse rate and skin temperature in babies up to 18 months of age and notifies caregivers with an alarm if readings fall outside of preset ranges. The sensors are embedded in a wearable boot.
  • Masimo previously disclosed it is exploring a potential spinoff of its consumer business into a separate company that is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Home, Medical Devices, Patient / Consumer, Provider
Related Articles:
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

Share This Article